Quercetin and Glioma: Which Signaling Pathways Are Involved?

Quercetin and Glioma: Which Signaling Pathways Are Involved? Publisher Pubmed

Tamtaji OR^{1, 6} ; Razavi ZS² ; Razzaghi N³ ; Aschner M⁴ ; Barati E⁵ ; Mirzaei H¹

Show Affiliations

1. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
2. Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran
3. Laboratory Sciences Research Centre, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
4. Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, 10461, NY, United States
5. Anatomical Sciences Research Center, Kashan University of Medical Sciences, Kashan, Iran
6. Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Current Molecular Pharmacology Published:2022

Abstract

Gliomas are the most common brain tumors. These tumors commonly exhibit continuous growth without invading surrounding brain tissues. Dominant remedial approaches suffer limited therapy and survival rates. Although some progress has been made in conventional glioma treatments, these breakthroughs have not yet proven sufficient for treating this malignancy. The remedial options are limited given gliomas' aggressive metastasis and drug resistance. Quercetin, a flavonoid, is an anti-oxidative, anti-allergic, antiviral, anti-inflammatory, and anticancer compound. Multiple lines of evidence have shown that Quercetin has anti-tumor effects, documenting this natural compound exerts its pharmacological effects by targeting a variety of cellular and molecular processes, i.e., apoptosis, metastasis, and autophagy. Herein, we summarize various cellular and molecular pathways that are affected by Quercetin in gliomas. © 2022 Bentham Science Publishers.

Related Docs

View other Related Docs

1. Therapeutic Potential of Resveratrol in the Treatment of Glioma: Insights Into Its Regulatory Mechanisms, Mini-Reviews in Medicinal Chemistry (2021)

2. Recent Advances in Glioblastoma Multiforme Therapy: A Focus on Autophagy Regulation, Biomedicine and Pharmacotherapy (2022)

3. Molecular Targets Underlying the Anticancer Effects of Quercetin: An Update, Nutrients (2016)

4. A Novel Approach to Glioblastoma Multiforme Treatment Using Modulation of Key Pathways by Naturally Occurring Small Molecules, Inflammopharmacology (2025)

5. Overview of Biological Effects of Quercetin on Ovary, Phytotherapy Research (2021)

6. Quercetin As a Jak–Stat Inhibitor: A Potential Role in Solid Tumors and Neurodegenerative Diseases, Cellular and Molecular Biology Letters (2022)

7. Apoptotic Effect of Atorvastatin in Glioblastoma Spheroids Tumor Cultured in Fibrin Gel, Biomedicine and Pharmacotherapy (2016)

8. Natural Products As Promising Targets in Glioblastoma Multiforme: A Focus on Nf-Κb Signaling Pathway, Pharmacological Reports (2020)

Experts (# of related papers)

View all Related Experts

Somayeh Ebrahimi Barough (1)

Esmaeil Sadroddiny (1)

Style	Citing Format
MLA	Tamtaji OR, et al.. "Quercetin and Glioma: Which Signaling Pathways Are Involved?." Current Molecular Pharmacology, vol. 15, no. 7, 2022, pp. 962-968.
APA	Tamtaji OR, Razavi ZS, Razzaghi N, Aschner M, Barati E, Mirzaei H (2022). Quercetin and Glioma: Which Signaling Pathways Are Involved?. Current Molecular Pharmacology, 15(7), 962-968.
Chicago	Tamtaji OR, Razavi ZS, Razzaghi N, Aschner M, Barati E, Mirzaei H. "Quercetin and Glioma: Which Signaling Pathways Are Involved?." Current Molecular Pharmacology 15, no. 7 (2022): 962-968.
Harvard	Tamtaji OR et al. (2022) 'Quercetin and Glioma: Which Signaling Pathways Are Involved?', Current Molecular Pharmacology, 15(7), pp. 962-968.
Vancouver	Tamtaji OR, Razavi ZS, Razzaghi N, Aschner M, Barati E, Mirzaei H. Quercetin and Glioma: Which Signaling Pathways Are Involved?. Current Molecular Pharmacology. 2022;15(7):962-968.
BibTex	@article{ author = {Tamtaji OR and Razavi ZS and Razzaghi N and Aschner M and Barati E and Mirzaei H}, title = {Quercetin and Glioma: Which Signaling Pathways Are Involved?}, journal = {Current Molecular Pharmacology}, volume = {15}, number = {7}, pages = {962-968}, year = {2022} }
RIS	TY - JOUR AU - Tamtaji OR AU - Razavi ZS AU - Razzaghi N AU - Aschner M AU - Barati E AU - Mirzaei H TI - Quercetin and Glioma: Which Signaling Pathways Are Involved? JO - Current Molecular Pharmacology VL - 15 IS - 7 SP - 962 EP - 968 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract